Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #751 to #800.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Huang Z, et al. Oncotarget (2015) cited as Ref 22 in DOI: 10.1038/s41392-020-0110-5: Title
  2. Jin X, et al. Tumour Biol (2017) cited as Ref 21 in DOI: 10.1038/s41392-020-0110-5: Title
  3. Hemmati HD, et al. Proc. Natl Acad. Sci. USA (2003) cited as Ref 20 in DOI: 10.1038/s41392-020-0110-5: Title
  4. Pardal R, et al. Nat. Rev. Cancer (2003) cited as Ref 19 in DOI: 10.1038/s41392-020-0110-5: Title
  5. Wang J, et al. Stem Cells (2010) cited as Ref 18 in DOI: 10.1038/s41392-020-0110-5: Title
  6. Li C, et al. Cancer Res. (2007) cited as Ref 17 in DOI: 10.1038/s41392-020-0110-5: Title
  7. Kanwar SS, et al. Mol. Cancer (2010) cited as Ref 16 in DOI: 10.1038/s41392-020-0110-5: Title
  8. Huntly BJ, et al. Nat. Rev. Cancer (2005) cited as Ref 15 in DOI: 10.1038/s41392-020-0110-5: Title
  9. Hill RP, et al. Cancer Res. (2006) cited as Ref 14 in DOI: 10.1038/s41392-020-0110-5: Title
  10. Matsui W, et al. Blood (2004) cited as Ref 13 in DOI: 10.1038/s41392-020-0110-5: Title
  11. Bjerkvig R, et al. Nat. Rev. Cancer (2005) cited as Ref 12 in DOI: 10.1038/s41392-020-0110-5: Title
  12. Ajani JA, et al. Semin. Oncol. (2015) cited as Ref 11 in DOI: 10.1038/s41392-020-0110-5: Title
  13. Visvader JE, et al. Cell Stem Cell (2012) cited as Ref 10 in DOI: 10.1038/s41392-020-0110-5: Title
  14. Shibata M, et al. Cancers (2019) cited as Ref 9 in DOI: 10.1038/s41392-020-0110-5: Title
  15. Shimokawa M, et al. Nature (2017) cited as Ref 8 in DOI: 10.1038/s41392-020-0110-5: Title
  16. Bonnet D, et al. Nat. Med. (1997) cited as Ref 7 in DOI: 10.1038/s41392-020-0110-5: Title
  17. Lapidot T, et al. Nature (1994) cited as Ref 6 in DOI: 10.1038/s41392-020-0110-5: Title
  18. Chen W, et al. Stem Cells Int. (2016) cited as Ref 5 in DOI: 10.1038/s41392-020-0110-5: Title
  19. Reya T, et al. Nature (2001) cited as Ref 4 in DOI: 10.1038/s41392-020-0110-5: Title
  20. Batlle E, et al. Nat. Med. (2017) cited as Ref 3 in DOI: 10.1038/s41392-020-0110-5: Title
  21. Sun Y, et al. Med. Res. Rev. (2015) cited as Ref 2 in DOI: 10.1038/s41392-020-0110-5: Title
  22. Siegel RL, et al. CA Cancer J. Clin. (2019) cited as Ref 1 in DOI: 10.1038/s41392-020-0110-5: Title
  23. Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5): Title
  24. Competing interests (from DOI: 10.1038/s41392-020-0110-5): Title
  25. Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5): Title
  26. Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5): Title
  27. Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5): Title
  28. Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5): Title
  29. Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5): Title
  30. Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  31. Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  32. Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  33. Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  34. Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  35. Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  36. Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  37. Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  38. Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  39. Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  40. Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  41. Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  42. Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5): Title
  43. Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  44. Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  45. Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  46. Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  47. Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  48. Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  49. Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5): Title
  50. Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5): Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:EntityUsage/Q8449"